期刊
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
卷 32, 期 11, 页码 2885-2899出版社
AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2021030333
关键词
hypomagnesemia; Bartter syndrome; genetic renal disease; magnesium; kidney stones; TRPM6; nephrocalcinosis; hypokalemia; mTOR; rag complex; salt wasting
资金
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organization for Scientific Research) grant [NWO VENI 016.186.012]
- Diabetes Fonds (Dutch Diabetes Research Foundation) [2017.81.014]
- Nierstichting (Dutch Kidney Foundation) [15OKG18]
- European Union [305608]
- IMAGEN project
- Health Holland, Top Sector Life Sciences Health [LSHM20009]
- Dutch Kidney Foundation [20OP1018]
- ZonMW [EJPRD2019-40]
Advances in genetic techniques have led to the identification of rare hereditary disorders of renal magnesium and salt handling over the last decade. A novel disease known as autosomal dominant kidney hypomagnesemia (ADKH-RRAGD) has been established, which combines an electrolyte-losing tubulopathy and dilated cardiomyopathy. Variants in the RRAGD gene were found to lead to an activation of mTOR signaling, indicating the critical role of Rag GTPase D in renal electrolyte handling and cardiac function.
Background Over the last decade, advances in genetic techniques have resulted in the identification of rare hereditary disorders of renal magnesium and salt handling. Nevertheless, approximately 20% of all patients with tubulopathy lack a genetic diagnosis. Methods We performed whole-exome and -genome sequencing of a patient cohort with a novel, inherited, salt-losing tubulopathy; hypomagnesemia; and dilated cardiomyopathy. We also conducted subsequent in vitro functional analyses of identified variants of RRAGD, a gene that encodes a small Rag guanosine triphosphatase (GTPase). Results In eight children from unrelated families with a tubulopathy characterized by hypomagnesemia, hypokalemia, salt wasting, and nephrocalcinosis, we identified heterozygous missense variants in RRAGD that mostly occurred de novo. Six of these patients also had dilated cardiomyopathy and three underwent heart transplantation. We identified a heterozygous variant in RRAGD that segregated with the phenotype in eight members of a large family with similar kidney manifestations. The GTPase RagD, encoded by RRAGD, plays a role in mediating amino acid signaling to the mechanistic target of rapamycin complex 1 (mTORC1). RagD expression along the mammalian nephron included the thick ascending limb and the distal convoluted tubule. The identified RRAGD variants were shown to induce a constitutive activation of mTOR signaling in vitro. Conclusions Our findings establish a novel disease, which we call autosomal dominant kidney hypomagnesemia (ADKH-RRAGD), that combines an electrolyte-losing tubulopathy and dilated cardiomyopathy. The condition is caused by variants in the RRAGD gene, which encodes Rag GTPase D; these variants lead to an activation of mTOR signaling, suggesting a critical role of Rag GTPase D for renal electrolyte handling and cardiac function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据